On November 13, MEDICA 2023, a world-renowned comprehensive medical exhibition, was held in Düsseldorf, Germany. BIOELAB went to the bank of the Rhine River and landed with chemistry、hematology and coagulation analyzers.
As the world's largest and most influential medical equipment exhibition, MEDICA is known as a symbol of new technology and innovation in the world's medical field, and is the vane of the medical industry. In this exhibition, all the world's famous large companies, manufacturers of conventional hospital equipment and medical products are launching the latest products and promoting new technologies at the exhibition.
In recent years, BIOELAB has continued to broaden the boundaries of its products, continue to deepen its cultivation in the field of IVD, innovate and empower clinical practice, gradually open up overseas markets, and is committed to allowing more patients around the world to enjoy professional and high-quality medical diagnostic technology.
As an "old friend" of MEDICA, BIOELAB's booth attracted most attention as soon as it was unveiled, and the innovative products on display attracted countless attention. In front of the booth, a large number of industry insiders stopped to pay attention, and the professional team of BIOELAB communicated and collided with experts, scholars and peers from all over the world to discuss the recent innovative scientific and technological achievements and discuss the future development.
The BIOELAB fully automatic biochemical analyzer series has been continuously upgraded as the "leading brand" for many years. The latest AS-800 has achieved a constant speed of 800 tests per hour, with over 80 biochemical reagent projects independently developed by the company. It can be said that it is a strong alliance and culmination, On-site hospital、 laboratory experts and dealers have been full of praise.
In the field of blood cells, the new EC-38 automatic three-part cell analyzer is small in shape, 80 samples/hour, 9μL ultra-micro blood collection, easy to achieve one-step inspection, speed is king! The product is not only widely praised in the country, this time out of the overseas, as soon as it appeared to attract countless viewers , many visitors immediately expressed a clear intention to cooperate.In the process of China's IVD climbing, China's wisdom continues to go abroad and show the hard power of China's intelligent manufacturing to the international market.
After more than ten years of hard work, BIOELAB has been walk to walk, covering multiple countries and regions such as China, Russia, the United States, Brazil, Southeast Asia, South Africa, etc., serving global healthcare and patients. In the future, in order to further benefit global customers, BIOELAB will accelerate its expansion in overseas markets, focus on the research and development of in vitro -diagnostic equipment, focus on improving manufacturing capabilities, provide practical and feasible overall solutions for the development of IVD device supply chain, and demonstrate the strength of Chinese manufacturing to the world.
